Brookline Capital Management Initiates Coverage on Envoy Medical (NASDAQ:COCH)

Equities researchers at Brookline Capital Management initiated coverage on shares of Envoy Medical (NASDAQ:COCH) in a research report issued on Monday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $9.00 price target on the stock. Brookline Capital Management’s price target would indicate a potential upside of 257.14% from the stock’s current price.

Separately, Ascendiant Capital Markets raised their price target on shares of Envoy Medical from $8.50 to $8.75 and gave the stock a “buy” rating in a report on Tuesday, September 3rd.

Envoy Medical Stock Up 3.3 %

COCH stock opened at $2.52 on Monday. Envoy Medical has a 52 week low of $0.75 and a 52 week high of $11.46. The firm’s fifty day moving average is $2.99 and its 200 day moving average is $3.17.

Envoy Medical (NASDAQ:COCH) last released its earnings results on Monday, August 12th. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The company had revenue of $0.07 million for the quarter, compared to the consensus estimate of $0.08 million. On average, research analysts forecast that Envoy Medical will post -1.22 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. WealthTrust Asset Management LLC purchased a new position in Envoy Medical, Inc. (NASDAQ:COCH) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 11,316 shares of the company’s stock, valued at approximately $44,000. WealthTrust Asset Management LLC owned about 0.06% of Envoy Medical as of its most recent SEC filing. 8.59% of the stock is owned by institutional investors and hedge funds.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.